摘要
分子生药学是生药学与分子生物学有机融合形成的新兴交叉学科,是一门在分子水平研究生药的分类与鉴定、栽培与保护及有效成分生产的科学。广藿香作为道地南药的研究热点,其在分子生药学方面的研究也一直受到学者们的关注,并在不断探索中取得了一定成果。该文综述了近年来广藿香的分子生药学相关研究,并对该领域进行了展望,以期为广藿香资源的保护、开发和利用提供参考。
Molecular pharmacognosy( MP) is a new interdisciplinary science,which integrates the pharmacognosy and molecular biology,and focuses on the crude drugs’ classification and identification,cultivation and protection,and production of active ingredients at the molecular level. Pogostemon cablin is one of the ten major southern medicines in China,MP research on this famous herb has developed on the basis of traditional research methods,and achieved certain results. This article summarized the MP research achievements of P. cablin in recent years,the prospect of this field is also discussed to provide references for the protection,development and utilization of P. cablin resources.
作者
安鑫
吴文如
来慧丽
杨璐
谭新宁
黄祖波
AN Xin;WU Wen-ru;LAI Hui-li;YANG Lu;TAN Xin-ning;HUANG Zu-bo(School of Pharmaceutial Sciences,Guangzhou University of Chinese Medicine,Guangzhou 510006,China;Guangdong Food and Drug Vocational College,Guangzhou 510000,China)
出处
《中国中药杂志》
CAS
CSCD
北大核心
2019年第22期4781-4785,共5页
China Journal of Chinese Materia Medica
基金
国家中医药管理局全国中药资源普查项目(GZY-KJS-2018-004)
国家中医药管理局全国中药特色技术传承人才培训项目(2015481601003)
广州中医药大学大学生创新创业训练计划项目(201910572161)
关键词
分子生药学
广藿香
基因
分子生物技术
molecular pharmacology
Pogostemon cablin
gene
molecular biological technology